News

Immunetune Establishes International Scientific Advisory Board LEIDEN, the Netherlands, January 11, 2022 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced the appointment of...

Immunetune Announces Presentations at Industry Conferences during November 2021   LEIDEN, the Netherlands, November 2, 2021 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced...

BIO-Europe, 25-28 October 2021 Sijme Zeilemaker, CEO of Immunetune, will be attending BIO-Europe, taking place October 25-28, 2021, in digital format. Feel free to reach out to us to set up a meeting and explore collaboration and investment opportunities. E-mail:...

BIO-Europe, 25-28 October 2021 Sijme Zeilemaker, CEO of Immunetune, will be attending BIO-Europe, taking place October 25-28, 2021, in digital format. Feel free to reach out to us to set up a meeting and explore collaboration and investment opportunities. E-mail:...

World Vaccine Congress Europe, 19-21 October 2021 Gerben Zondag, Founder & COO of Immunetune, will be attending the World Vaccine Congress Europe, taking place October 19-21, 2021, in Barcelona, Spain. Feel free to reach out to us to set up a meeting and explore...

Immunetune to Present Data on Neoantigen Cancer Vaccine Platform at SITC 2021 LEIDEN, the Netherlands, October 1, 2021 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced the...

Immunetune Strengthens Team by Appointing Sijme Zeilemaker as Chief Executive Officer LEIDEN, the Netherlands, August 11, 2021 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced...